4005.0: Tuesday, November 18, 2003: 8:30 AM-10:00 AM | |||
Poster | |||
| |||
| Learning Objectives: Refer to the individual abstracts for learning objectives | |||
| See individual abstracts for presenting author's disclosure statement and author's information. | |||
| Tobacco-use prevention and cessation services in underserved communities: Lessons learned through the American Legacy Foundation/Community Voices Tobacco Initiative Cheryl A. Ferguson, MPH, Barri B. Burrus, PhD, Kavita P. Ahluwalia, DDS, MPH, Debra Klecan, PhD, Lisa Gaarde Hartsock, MPH, Melanie Mack, MSW, Jodie Ruland, MDiv, Paul Akmajian, MFA, Amber Rickert, MPH, MSW | |||
| A health system's approach to tobacco Julie Osgood, MS | |||
| Adoption, reach and implementation of a novel smoking control program: Analysis of a public utility--research organization partnership Russell Glasgow, PhD, Shawn M. Boles, PhD, Edward Lichtenstein, PhD, Michael E. Lee, Lyn Foster | |||
| Do self-efficacy for resisting smoking and nicotine dependence levels predict stage of change for quitting in adolescent smokers? Yu-Mei Schoenberger, MPH, Connie L. Kohler, DrPH, Amy W Wear, Erin R. Smith, MPH | |||
| Indiana smoking cessation program network Karen Bruner Stroup, PhD, Hannah Thomason, BA | |||
| Smoking cessation training for healthcare providers: Alabama tobacco free families Myra A. Crawford, PhD, MPH, Lesa L. Woodby, PhD, MPH, Tamela J. Turner, PhD, MEd, MCn, Jean Marie White, BA | |||
| Thinking outside the box but within the system: Recommendations for expanding statewide tobacco cessation services Elizabeth W. Edsall, MSc, Linda A. Bailey, JD, MHS | |||
| Facilitators and barriers to providing tobacco dependence treatment for students in schools Mia Hanos Zimmermann, MPH, Wendy A. Ritch, MA, MTS, Michael Burke, EdD | |||
| Using existing campus resources to institutionalize cessation services for 18-24 year olds Laurie J. Mazzei, MPH, Kay M. Adkins, MPH, Michele Jacknik, MSEd, Veronica Acosta-DePrez, PhD, CHES, Mohammed Forouzesh, MPH, PhD | |||
| Results of a phase 1 safety and immunogenicity trial with NicVAX, a conjugated nicotine vaccine Arjen De Vos, MD, PhD, Gary Horwith, MD, Ali Fattom, PhD, Robert Naso, PhD, Steven Fuller, PhD, Larry R. Muenz, PhD, Ann Kennedy, MD, Sofiane Ennifar, PhD | |||
| Organized by: | Alcohol, Tobacco, and Other Drugs | ||